Global PCR and Real-Time PCR Testing Market Driven by Need for Early Disease Detection

By LabMedica International staff writers
Posted on 09 Sep 2022

Image: The global PCR and real-time PCR testing market is expected to approach USD 25 billion in 2026 (Photo courtesy of Pexels)

The polymerase chain reaction (PCR) and real-time polymerase chain reaction testing market consists of sales of PCR and real-time PCR testing services and related products. The real-time RT-PCR technique is a highly sensitive and specific testing method that can deliver a reliable diagnosis in as fast as three hours, unlike the other laboratory tests that take an average of 6 to 8 hours. Real-time RT-PCR is significantly faster and has a lower potential for contamination or errors as the entire process is within a closed tube. With the onset of chronic diseases, there is focus on detecting the cause of the disease to decrease its onset on people, for drug discovery and for starting the appropriate treatment at the appropriate time, which enables faster cure, saves maximum lives and decreases after-effects.

Early detection plays a key role in treating COVID-19 patients. Real-time RT-PCR is considered to be the most accurate method available for the detection of coronavirus. The RT-PCR test is the standard test for coronavirus and is used for its high sensitivity, which enables it to detect early infection. This has created a huge demand for PCR testing kits. Thus, the need for early detection of COVID-19 is driving the growth of the PCR and real-time PCR testing market. Additionally, most companies are coming up with real-time RT-PCR tests for coronavirus, thus contributing to the market growth. The global PCR and real time PCR testing market is expected to grow at a CAGR of 6.2% from USD 18.5 billion in 2021 to USD 19.64 billion in 2022 and further grow to USD 24.61 billion in 2026 at a CAGR of 5.8%. In 2021, Asia Pacific was the largest PCR and real-time PCR testing market, followed by Western Europe.

These are the latest findings of Research and Markets (Dublin, Ireland), a market research firm.

The players operating in the PCR and real-time PCR testing market manufacture, develop, or deploy related devices, reagents, and services, to detect and measure DNA (or RNA) in a sample. PCR and real-time PCR testing find applications in cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays. The main products involved in PCR and real-time PCR testing are consumables and reagents, instruments, and software and services. The technologies involved in PCR and real-time PCR testing are quantitative PCR and digital PCR that find various applications such as clinical diagnostics, life science research, industrial applications, and others. The need for early detection of diseases is expected to continue driving the global PCR and real time PCR testing market. The players operating in the PCR and RT PCR testing market are coming up with new test kits and systems for the diagnosis of diseases. However, the development of alternative technologies such as CRISPR is expected to hinder market growth.

Related Links:
Research and Markets